Home - Products - Cell Cycle/DNA Damage - HDAC - BRD9757

BRD9757

CAS No. 1423058-85-8

BRD9757( BRD 9757 )

Catalog No. M11783 CAS No. 1423058-85-8

BRD9757 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	215	Get Quote
10MG	302	Get Quote
25MG	482	Get Quote
50MG	696	Get Quote
100MG	972	Get Quote
500MG	1953	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BRD9757
Note

Research use only, not for human use.
Brief Description

BRD9757 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.
Description

BRD9757 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM, displays >20-fold selectivity over HDAC1/3 and other HDAC isoforms.
In Vitro

——
In Vivo

——
Synonyms

BRD 9757
Pathway

Cell Cycle/DNA Damage
Target

HDAC
Recptor

HDAC
Research Area

——
Indication

——

Chemical Information

CAS Number

1423058-85-8
Formula Weight

127.143
Molecular Formula

C6H9NO2
Purity

>98% (HPLC)
Solubility

——
SMILES

C1CC=C(C1)C(=O)NO
Chemical Name

N-hydroxycyclopent-1-ene-1-carboxamide

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Wagner FF, et al. J Med Chem. 2013 Feb 28;56(4):1772-6.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Givinostat hydrochlo...

Givinostat hydrochloride is an inhibitor of HDAC with IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride exhibits anti-inflammatory, anti-angiogenic, and antineoplastic activities.
SR-18292

SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
SB-379278A

A potent and selective HDAC8 inhibitor with IC50 of 0.5 uM.

Sign In Join Free